NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 96 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,918 | +42898.6% | 57,867 | +4.1% | 0.00% | -55.6% |
| Q2 2023 | $144 | -38.2% | 55,569 | -2.6% | 0.01% | -35.7% |
| Q1 2023 | $233 | -21.3% | 57,066 | -3.1% | 0.01% | -22.2% |
| Q4 2022 | $296 | -100.0% | 58,869 | -66.4% | 0.02% | -88.1% |
| Q3 2022 | $2,291,000 | +5.5% | 175,183 | +3.5% | 0.15% | +11.9% |
| Q2 2022 | $2,171,000 | -42.2% | 169,337 | -31.3% | 0.14% | -32.5% |
| Q1 2022 | $3,756,000 | -17.4% | 246,322 | -4.1% | 0.20% | -10.3% |
| Q4 2021 | $4,547,000 | -21.9% | 256,758 | -7.3% | 0.22% | -27.1% |
| Q3 2021 | $5,822,000 | +3.1% | 276,990 | -3.3% | 0.31% | +1.7% |
| Q2 2021 | $5,649,000 | -25.2% | 286,458 | +10.2% | 0.30% | -33.7% |
| Q1 2021 | $7,554,000 | – | 259,841 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 18,136,735 | $237,228,000 | 52.50% |
| Ponoi II Management, LLC | 1,298,908 | $16,990,000 | 44.41% |
| Ponoi Management, LLC | 1,298,908 | $16,990,000 | 23.20% |
| Euclidean Capital LLC | 746,674 | $9,766,000 | 9.07% |
| StepStone Group LP | 1,573,357 | $20,580,000 | 2.93% |
| Logos Global Management LP | 850,000 | $11,118,000 | 1.37% |
| First Light Asset Management, LLC | 955,505 | $12,498,000 | 1.26% |
| GREAT POINT PARTNERS LLC | 316,256 | $4,137,000 | 1.00% |
| Rubric Capital Management LP | 877,161 | $11,473,000 | 0.58% |
| Avidity Partners Management LP | 1,798,100 | $23,519,000 | 0.48% |